Powered By
NONSTEROIDAL ANTI-INFLAMMATORY DRUG
| The Relafen brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your healthcare provider about safe options for transitioning to a different treatment. |
Overview
Relafen was a prescription medication that was approved by the U.S. Food and Drug Administration (FDA) to treat pain, fever, and inflammation. It was sometimes prescribed to treat pain, stiffness and discomfort caused by lupus in joints and other tissues. Relafen was also known by its drug name, nabumetone
Relafen was a nonsteroidal anti-inflammatory drug (NSAID). Nabumetone was believed to work by inhibiting the production of chemicals that promote inflammation in the body.
How was it taken?
Relafen was taken orally as a tablet once or twice a day.
Side effects
Common side effects of Relafen included vomiting, constipation, nausea, gas, diarrhea, headache, dizziness, dry mouth, mouth sores, and drowsiness.
Rare but serious side effects included an increased in the risk of stroke, heart attack, fluid retention, edema (swelling) and gastrointestinal bleeding.
For more information about this treatment, visit:
Become a member to get even more
Join
